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Amyotrophic lateral sclerosis (ALS) is an adult-onset progressive neurodegenerative disease affecting upper and lowermotoneurons
(MNs). Although the motor phenotype is a hallmark for ALS, there is increasing evidence that systems other than the efferent MN
system can be involved. Mutations of superoxide dismutase 1 (SOD1) gene cause a proportion of familial forms of this disease.
Misfolding and aggregation of mutant SOD1 exert neurotoxicity in a noncell autonomous manner, as evidenced in studies using
transgenic mouse models. Here, we used the SOD1G93A mouse model for ALS to detect, by means of conformational-specific anti-
SOD1 antibodies, whether misfolded SOD1-mediated neurotoxicity extended to neuronal types other than MNs. We report that
large dorsal root ganglion (DRG) proprioceptive neurons accumulate misfolded SOD1 and suffer a degenerative process involving
the inflammatory recruitment of macrophagic cells. Degenerating sensory axons were also detected in association with activated
microglial cells in the spinal cord dorsal horn of diseased animals. As large proprioceptive DRG neurons project monosynaptically
to ventral horn MNs, we hypothesise that a prion-like mechanism may be responsible for the transsynaptic propagation of SOD1
misfolding from ventral horn MNs to DRG sensory neurons.
1. Introduction
Amyotrophic lateral sclerosis (ALS) is a devastating adult-
onset neurodegenerative disease which affects upper and
lower motoneurons (MNs) and causes progressive paralysis
and atrophy of voluntary muscles. Death usually occurs as
a result of respiratory failure, 3–5 years after the onset of
clinical symptoms [1, 2]. While the majority of ALS cases are
sporadic, 10% are familial (fALS), with an autosomal pattern
of inheritance. A variety of mutations in the homodimeric
protein Cu/Zn superoxide dismutase (SOD1) have been
linked to 20% of fALS cases [3] and transgenic mice carrying
mutated human SOD1 have been extensively employed as a
model to investigate both familial and sporadic ALS [4, 5].
Although the motor phenotype derived from corticospinal
tract and peripheral motor nerve degeneration is a hallmark
of ALS, there is increasing evidence that ALS could be
a multisystem disorder affecting also the somatosensory
cortex [6], autonomic system [7], spinocerebellar tracts [8],
and serotoninergic neurons [9]. The involvement of the
peripheral sensory system has also been reported in ALS
patients, particularly after electrophysiological examination
[10] and also in mutant SOD1 mouse models [11]. However,
the evidence of pathological changes in peripheral sensory
neurons is scarce. In a previous study using SOD1ALSmurine
models, we showed that an antibodywhich cross-reactedwith
neurotoxic species of mutant SOD1 provided an excellent
tool for revealing this pathology in other neuronal types
besides spinal cord MNs [12, 13]. In these studies we showed
that ALS-linked neurodegenerative pathology could also be
detected inmotor cortexMNs and in other less expectedCNS
regions, such as serotonin-containing neurons in the raphe,
noradrenergic neurons in the locus coeruleus, and Purkinje
neurons in the cerebellum.
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Here, we report that using our anti-misfolded SOD1
antibodies [14] it was also possible to detect degenerating
sensory neurons in the dorsal root ganglion (DRG) of ALS
SOD1G93A mice. Degenerating sensory axons in spinal cord
dorsal nerve roots were also found in parallel with the
progression of the disease. Dying DRG neurons displayed a
nonapoptotic phenotype and recruited macrophage cells in
a similar way to that observed in ventral horn MNs. These
results suggest that the fundamental mechanisms by which
mutant SOD1 exerts neurotoxicity are not neuronal type-
specific.
2. Materials and Methods
2.1. Animals and Tissue Preparation. The transgenic animals
used in this study were B6SJL-Tg (SOD1-G93A) 1Gur/J
(SOD1G93A) mice obtained from Jackson Laboratory (Bar
Harbor, ME, USA). Once symptoms had developed, disease
progression was quite rapid and caused the death of most
of the animals within 128.9 ± 9.1 days. All the experimental
procedures were approved by the Ethical Committee for
Animal Testing of the University of Lleida in line with the
norms of the Generalitat de Catalunya (DOGC 2073, 1995).
For light microscopy immunocytochemistry, the animals
were deeply anaesthetized with pentobarbital, and transcar-
dially perfused with physiological saline solution followed by
4% paraformaldehyde (PFA) in 0.1M phosphate buffer (PB)
at pH 7.4. After 24 hours in PFA, samples were transferred
to 30% sucrose in 0.1M PB and 0.02% sodium azide for
cryoprotection and were then frozen for cryostat sectioning.
For electron microscopic examination, animals were
perfused with 1% PFA and 1% glutaraldehyde in 0.1MPB
at pH 7.4. DRG and their ventral and dorsal nerve roots
(VRs and DRs, resp.) were separately dissected and pro-
cessed: they were then postfixed in 1% osmium tetroxide
and embedded with Embed 812 epoxy resin according to
standard procedures. Ultrathin sections were counterstained
with uranyl acetate and lead citrate and observed in a Zeiss
EM 910 (Zeiss, Oberkochen, Germany) electron microscope.
Semithin sections (1 𝜇m thick) stained with methylene blue
were also examined and imaged using an Olympus 60X/1.4
NA PlanApo oil immersion objective (Olympus, Hamburg,
Germany) and a DMX 1200 Nikon (Tokyo, Japan) digital
camera.
2.2. Immunohistochemistry and Image Analysis. Cryostat
sections (16 𝜇m thick) of PFA-fixed DRGs were pretreated
with phosphate buffered saline (PBS) containing 0.1% Triton
X-100, blocked in 3% normal goat serum, and incubated
overnight with primary antibodies at 4∘C. The primary anti-
bodies used were the following: (1) AJ10 antibody was pro-
duced in our laboratory by immunizing rabbits with a human
SOD1 peptide sequence (VKVWGSIKGLTEGLHGFHVHE-
FGDNTAGC); this antibody is specific for misfolded ALS-
linked mutant human SOD1conformers and barely reacts
with wild-type (WT) human SOD1 [14] rabbit polyclonal
anti-P2X4 (1 : 500; Alomone Labs, Jerusalem, Israel); some
lots of this antibody, such as lot AN-04 and AN-05, cross-
react with high affinity with ALS-linked misfolded con-
formers of SOD1 [12, 13]; (3) rat monoclonal anti-Mac-2
(1 : 800, Antibodies onlineGMBH,Aachen, Germany); (4) rat
monoclonal anti-mouse CD68 (1 : 100; AbD Serotec, Oxford,
UK); (5) mouse monoclonal anti-calcitonin gene-related
peptide (CGRP, 1 : 100; Abcam, Cambridge, UK; ab81887); (6)
goat polyclonal anti-parvalbumin (PV, 1 : 1000; Swant, Marly,
Switzerland; pv-235); (7) guinea pig polyclonal anti-substance
P (SP, 1 : 1000; Abcam; ab10353); and (8) mouse monoclonal
anti-neuron-specific class III 𝛽-tubulin (TUJ1, 1 : 500, RD
Systems, Minneapolis, MN, USA; mab1195).
After washing in PBS, sections were incubated with
appropriate secondary antibodies (1 : 500) whichwere labeled
with either Alexa Fluor 488 (Invitrogen), Cy3, or Cy5 (Jack-
son Immunoresearch Laboratories, West Grove, PA, USA).
Sections were treated with 4󸀠,6-diamidino-2-phenylindole
dihydrochloride (DAPI, 50 ng/mL) for nuclear fluorescent
staining. Some sections were also incubatedwith the isolectin
B4 from Bandeiraea simplicifolia conjugated with fluorescein
isothiocyanate (FITC, 1mg/mL, Sigma).
Mounted slices were examined and imaged with an
Olympus BX51 epifluorescence microscope equipped with a
DP30BW camera or a FluoView 500 Olympus confocal laser-
scanning microscope.
Morphometry was performed on digital images using
ImageJ (National Institutes of Health, Bethesda, MA, USA)
or Visilog 6.3 software (Noesis, Orsay, France).
2.3. Statistical Analysis. All data are expressed as mean
± SEM. The statistical analysis was assessed using either
Student’s 𝑡-test or one-way analysis of variance (ANOVA) fol-
lowed by a post hoc Bonferroni’s test.The level of significance
was chosen as 𝑃 < 0.05.
3. Results
3.1. Nerve Pathology in Ventral and Dorsal Roots of SOD1G93A
Mice. The extent of sensory system involvement in ALS and
its correlationwith themore genuine pathology seen inmotor
systemwere analyzed.The total number of apparently healthy
axons contained in L4 VRs (motor) and DRs (sensory) was
counted in semithin plastic sections taken from SOD1G93A
mice. These animals develop overt neuromuscular clinical
deficits starting from around postnatal day (P) 90; this was
followed by paralysis and then death at around P130 [15, 16].
As can be observed in Figures 1(a)–1(c), the number of VR
motor axons started to decline from P90 and, as expected,
about 50 % of these axons had been lost by P120. A similar
profile of nerve degeneration, though on a different scale, was
observed for the sensory axons of the DRs. This severe nerve
pathology was not, however, reflected as an axonal loss in our
DR counts. This is because the degenerating sensory axons
had still not disappeared in end-stage animals at the moment
of sampling (Figures 1(g)–1(i)). In both the VRs and DRs,
we observed more or less extensive Wallerian-like degen-
erative changes, respectively, with abundant myelin debris
and myelin ovoids engulfed by phagocytic cells (Figures 1(d),
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Figure 1: Morphometric analysis of motor (L4 VRs, (a)–(f)) and sensory (L4 DRs, (g)–(l)) axons fromWT and SOD1G93A mice. An analysis
was performed on 1𝜇m semithin plastic transversal sections ((b), (c), (h), and (i)). ((a)–(c) and (g)–(i)) Counts showed a significant loss
of the total number of motor, but not sensory, axons in the end-stage (P120) SOD1G93A mice ((a) and (g)). ((d)–(f) and (j)–(l)) A frequency
distribution analysis ofmyelinated axon size inWTVRs showed a clear bimodal profile (f) indicative of axons coming from𝛼-MNs (large) and
𝛾-MNs (small); note the selective loss of large axons in SOD1G93A mice. Representative images ofWT and SOD1G93A ventral nerve are shown
in (d) and (e); note the presence of abundant degenerating axons in SOD1G93A animals. Although there was no evidence of the loss of sensory
axons in dorsal nerve roots in SOD1G93A mice, a more detailed examination of nerve profile morphology ((j) and (k)) revealed the presence of
moderate numbers of axons exhibiting significant degrees of swelling (∗) and other degenerating features. A frequency distribution analysis of
myelinated axon size in dorsal nerve roots (l) reflected the appearance of a new population of large diameter (degenerating) sensory axons in
SOD1G93A samples (indicated by a double arrowed line).The bars in the graphs represent the mean ± SEM values of counts performed in 2–11
animals per age and experimental condition; ∗∗𝑃 < 0.01 versus WT, one-way ANOVA, Bonferroni’s post hoc test). Scale bar in 𝐷 = 10 𝜇m
(valid for (e), (j), and (k)).
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Figure 2: Continued.
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Figure 2: Degenerative changes in motor and dorsal axons were highlighted using Mac-2 immunolabeling (green), as a marker for activate
macrophage infiltration, and p75 (a low affinity neurotrophin receptor that is upregulated in denervated Schwann cells) immunofluorescence
(red).These two proteins were barely visible in the VRs ((a)–(c)) and DRs ((g)–(i)) (delimited by dashed lines) fromWT animals. In contrast,
Mac-2 and p75 were markedly upregulated in both the VRs ((d)–(f)) and DRs ((j)–(l)). The density of Mac-2 positive cells was quantified at
different postnatal ages (m); the bars in the graph represent the mean ± SEM values for counts performed in 5 nerve roots (L4) of 3 animals
per age and experimental condition; ∗∗∗𝑃 < 0.001 versus its respective WT nerve root (one-way ANOVA, Bonferroni’s post-hoc test). VR:
ventral nerve root, DR: dorsal nerve root. Scale bars: 150 𝜇m in (c) and (i) (valid for (a), (b), (g), and (h)), 50 𝜇m in (f), and (g) (valid for (d),
(e), (j), and (k)).
1(e), 1(j), and 1(k)). Whereas axonal loss mainly involved
large motor axons (>6𝜇m diameter) in VRs, in DRs, axonal
depletion resulted in an unaltered frequency distribution of
axonal caliber; the only exception to this was the appearance
of a new population of large (>8 𝜇m diameter) swollen and
abnormal axons (Figures 1(f) and 1(l)).
The density of activated phagocytic cells was evaluated
using Mac-2 immunostaining. It is known that both blood-
borne macrophages and Schwann cells phagocyting degen-
erating myelin after peripheral nerve injury display Mac-
2 immunoreactivity [17]. In VRs and DRs of WT mice
Mac-2 positive cells were scarce (Figures 2(a) and 2(g)). In
SOD1G93A animals, the density of Mac-2 positive phagocytes
was found to be slightly greater in VRs at P25 and P40 (Fig-
ure 2(m)). It was, however, possible to observe a progressive
increase in VR phagocytes after P60 (Figures 2(d) and 2(m)).
DR phagocytes followed a similar, although damped, profile
(Figures 2(j) and 2(m)).
To additionally evaluate DR pathology in SOD1G93A
animals, the extent of Schwann cell denervation was analyzed
by detecting the expression of the low affinity nerve growth
factor (NGF) receptor, p75. This receptor has been found to
be dramatically upregulated in Schwann cells after peripheral
nerve injury [18, 19]. Whereas no p75 positive cells were
found in VRs and DRs fromWT animals (Figures 2(b), 2(c),
2(h), and 2(i)), p75 was found highly to be upregulated in
both nerve roots of SOD1G93A mice during the end-stage
of the disease (Figures 2(e), 2(f), 2(k), and 2(l)), with the
reaction being stronger in VRs (the numbers of p75 positive
cells/1,000 𝜇m2 were 2.3 ± 0.1 for VRs and 1.5 ± 0.1 for DRs;
𝑛 = 30 fields, 3 mice per condition, 𝑃 < 0.001, Student’s 𝑡-
test).
After electron microscopy examination, it was found that
both VRs and DRs underwent similar qualitative degen-
erative changes. These changes were highly comparable to
those described during Wallerian degeneration, which takes
place in the nerve segment distal to the site of lesion after
axonal transection [20]. The most conspicuous alteration
was extensive myelin degradation, with the formation of
myelin ovoids and the presence of phagocytic cells engulfing
large amounts of lamellar myelin debris (Figures 3(a) and
3(b)). Signs of axonopathy, such as axonal swelling, abnormal
accumulations of organelles, and altered mitochondria, were
also seen. Ultrastructural signs of axonal regeneration were
also observed, but only in VRs; these involved the presence
of folded basal lamina sheaths in which some Schwann
cell processes enveloped thin growing axon profiles (Figures
3(c) and 3(d)). The folded basal lamina tubes represented
empty “ghosts” of the original nerve fibers that were lost
after degeneration and served as a scaffold for newly formed
axonal sprouts (Figure 3(c)). Giant axonal profiles filled
by vesicular organelles, mitochondria, and cytoskeletal fil-
aments surrounded by thin nonmyelinating Schwann cells
were also observed (Figure 3(d)). This organization was typ-
ical of the growth cone ultrastructure. These results suggest
that although analogous degenerative pathomorphological
changes were present in sensory and motor axons, the
regenerative response was only detected in the latter.
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Figure 3: The ultrastructural morphology of VRs ((a), (c), and (d)) and DRs (b) from end-stage SOD1G93A mice. From a qualitative point
of view, similar Wallerian-like degenerative changes could be observed in both VRs (a) and DRs (b); phagocytic cells (shaded in green), in
which the nucleus is dashed in blue, appear to engulf the myelin debris (shaded in red); apparently normal myelinated axons are dashed in
yellow and Schwann cell profiles are dashed in magenta. ((c)–(d)) In ventral roots it is possible to observe some regenerating axons (yellow in
(c)) growing inside the ghosts of folded basal lamina profiles (green in (c)) filled with Schwann cell pedicles (magenta in (c)). Occasionally, a
large growth cone (yellow in (d)) filled with organelles and surrounded by Schwann cell profiles (magenta in (d)) can be detected. Scale bars:
5 𝜇m in (a), 2.5 𝜇m in (b), 0.5 𝜇m in (c), and 1 𝜇m in (d).
3.2. Dorsal Root Ganglion Cell Degeneration in SOD1G93A
Mice. Misfolded SOD1 accumulation in MN cell bodies has
been shown to be useful tool for monitoring cellular dys-
function in SOD1 mouse models of ALS [21]. We generated
an antibody which was able to recognize misfolded confor-
mations of SOD1 shared by different ALS-linked mutations
[14]. Here, this antibody was used to explore whether sensory
axon degeneration involved the accumulation of misfolded
SOD1 in DRG neuronal cell bodies. In end-stage ani-
mals, some DRG neurons displayed strong misfolded SOD1
immunoreactivity which sometimes extended to neuritic
profiles (Figures 4(a)–4(c)). Some of these presented signs of
cytoplasmic fragmentation indicative of cell body disruption.
As already described in MN cell bodies, degenerating DRG
neurons with misfolded SOD1 recruited phagocytic cells; this
was demonstrated using the macrophage/microglia marker
CD68 (Figures 4(d)–4(g)).Theneuronswithmisfolded SOD1
accumulation were significantly larger than the rest of the
DRG neuronal population (mean area in 𝜇m2, misSOD1+
neurons: 1099.6 ± 52.5, 𝑛 = 16, and misSOD1− neurons:
706.2 ± 34.3, 𝑛 = 146, 𝑃 < 0.001; mean diameter in
𝜇m, misSOD1+ neurons: 36.9 ± 1, 𝑛 = 16, and misSOD1−
neurons: 28.7 ± 0.7, 𝑛 = 146, 𝑃 < 0.001; Student’s 𝑡
test). When individual values were plotted in a histogram
frequency graph, the selective involvement of the large cell
population inmisfolded SOD1 accumulation was clearly seen
(Figure 4(h)).
It is possible to further distinguish the heterogeneous
cellular population present in DRG according to specific
cytochemical properties. CGRP and SP are contained in
small, unmyelinated, peptidergic, and nociceptive primary
sensory neurons; the isolectin IB4 is also a marker for small,
unmyelinated, but nonpeptidergic, sensory neurons; and PV
labels large, proprioceptive, neurons that innervate muscle
spindles [22, 23]. All of thesemarkers were used here in order
to determine whether misfolded SOD1 had accumulated in
a particular subpopulation of DRG neurons. We did not
observe any misfolded SOD1 positive neurons containing
CGRP, SP, or IB4 labeling (Figures 5(a)–5(i)). However, the
misfolded SOD1 positive neurons displayed highly intense
PV immunolabeling, indicating that they belong to the
proprioceptive population (Figures 5(j)–5(l)).
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Figure 4: ((a)–(c)) Misfolded SOD1 (misSOD1) immunolabeling using AJ10 antibody (red) reveals highly immunoreactive neuronal somata
within the DRG (delimited in (a)) of end-stage (P120) SOD1G93A mice. Some neuronal somata display cytoplasmic fragmentation indicative
of degenerative changes (arrows in (b)); nuclei, counterstained with DAPI (blue), do not show apoptotic morphology (arrows in (c)). ((d)–
(g)) Misfolded SOD1 immunolabeling (red) was combined with an anti-CD68 antibody (green) to reveal activated macrophagic cells; DAPI
(blue) was used for nuclear staining. A degenerating neuron expressingmisfolded SOD1 (delimited in (d)) and displaying clustered profiles of
CD68 positive phagocytic cells is shown in high magnification in (e)–(g). (h) A frequency distribution profile of the size of the DRG neuron
somata containing misfolded SOD1 with respect to that of the whole neuronal population; note that misfolded SOD1 positive neurons belong
to the large-sized (presumably proprioceptive) population. Scale bars: 80𝜇m in (a), 40𝜇m in (b), (c), (d), and (g) (also valid for (e) and (f)).
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Figure 5: Micrographs taken from the DRGs of end-stage (P120) SOD1G93A mice. Misfolded SOD1 (misSOD1) immunolabeling using AJ10
antibody (red) was combined with several markers for DRG neuronal types, as indicated (green). ((a)–(i)) Misfolded SOD1 immunoreactive
neurons do not colocalize with the neuropeptides CGRP and SP, or with IB4, all of which are markers for neuronal types other than
proprioceptive. ((j)–(l)) However, neurons containing misfolded SOD1 colocalize with PV, a marker for proprioceptive sensory neurons. In
some cases, DAPI was used for nuclear staining (blue).The prominent background observed in (c) and (d) is due to an unspecific connective
tissue reaction involving the secondary antibody when a mouse monoclonal was used as a primary antibody. Scale bars = 200𝜇m.
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Figure 6: (a) Semithin plastic section of a DRG from end-stage (P120) SOD1G93A mice showing a degenerating, microvacuolated, large
neuronal soma, which is surrounded by apparently normal medium-sized neuronal cells. ((b) and (c)) The cells indicated in the semithin
sections were examined by electron microscopy which revealed a well-preserved organelle structure in the medium-sized neuronal cell (b)
and extensive microvacuolization in the degenerating large soma (c). (d) A large myelinated axonal profile adjacent to the DRG sensory
neurons shows an accumulation of highly vacuolated mitochondria with a comparable morphology to that of degenerating mitochondria
typically described in motor axons of SOD1G93A mice (as shown in (e), taken from a sample of facial nucleus). Scale bars: 20 𝜇m in (a), 0.5 𝜇m
in (b) and (c), and 1.5 𝜇m in (d) and (e).
Large neurons with degenerative changes can also be
easily detected in semithin sections of DRGs from terminal
SOD1G93A mice. Microvacuolization was the main alteration
observed in these neurons. Their nuclei did not display
the typical apoptotic morphology but appeared shrunken
and exhibited a loss of their normal, well-defined circular
shape (Figure 6(a)). Under electron microscopy, the vacuoles
displayed a round profile and were delimited by a membrane,
suggesting that they originate from the vacuolar disruption
of the endoplasmic reticulum. The mitochondria showed
a round, condensedmorphology (Figure 6(c), comparedwith
Figure 6(b)). Large myelinated axons adjacent to degenerat-
ing DRG neuronal cell bodies often exhibited an accumu-
lation of highly prominent vacuolated mitochondria which
displayed the typical alteration that has been described in
motor axons and dendrites of SOD1G93A mice (Figures 6(d)
and 6(e)).
To assess whether degenerating sensory axons entering
the spinal cord involves the activation of microglial cells, the
density of CD68-positive microglial profiles was analyzed in
dorsal areas of spinal cord gray matter (Figures 7(a)–7(e)).
For comparisons, counts were also performed in ventral horn
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Figure 7: ((a)–(d)) Double immunolabeling with TUJ1 (to label neuronal profiles, red), and anti-CD68 (to reveal microglial cells, green)
antibodies in ventral ((a), (c)) and dorsal ((b), (d)) horn of WT ((a), (b)) and end-stage SOD1G93A ((c), (d)) mice; L: lateral, M: medial.
CD68-positive profiles were rarely detectable in WT samples, but they were present in either large or moderate quantities in the ventral and
dorsal horn, respectively, of SOD1G93A samples. In SOD1G93A dorsal horns, it was possible to observe some infiltratingmicroglial cells adjacent
to medially located (presumably proprioceptive) axon fascicles, entering the spinal cord (arrows in (d)). (e) Quantification of CD68-positive
profiles in the spinal cord of WT and end-stage SOD1G93A mice. Bars represent mean ± SEM values for counts performed in 6–11 fields of 2
animals per experimental condition; ∗∗∗𝑃 < 0.001 versus WT (one-way ANOVA, Bonferroni’s post hoc test). Scale bar in (b) = 100 𝜇m (also
valid for (a), (c), and (d)).
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gray matter, in which degenerating MNs were located and
neuroinflammatory microglial activation has already been
well established in themodel. As expected, we found a notable
infiltration of CD68 positivemicroglia aroundmotoneuronal
somata. A moderate increase in CD68 positive microglial
cells was also observed in the dorsal gray matter; some of
these profiles were seen adjacent to medially located fascicles
of sensory axons corresponding to sensory axons originating
from proprioceptive sensory neurons [24].
4. Discussion
Although ALS is mainly characterized by motor axon degen-
eration and the loss of lower and upper MNs, there is a
considerable amount of data concerning the abnormalities in
the sensory system in both human and experimental models.
For instance, neuropathological studies have demonstrated
reductions ofmore than 50% in large L5DRG cell bodies [25],
while substantial degeneration of sensory axons in the sural
and peroneal nerves has also been observed in ALS patients
[26–28]. By means of neurophysiological explorations, it has
been shown that 20–60% of ALS patients have abnormalities
in their sensory system [10, 29]. Consistent with human
pathology, sensory nerve degeneration has also been evi-
denced in SOD1G93A mouse models [11, 30, 31]. Here, we
confirm thatDRG sensory neurons and their axons are clearly
damaged in ALS SOD1G93A mice and show that misfolded
SOD1 accumulation is on the base of this process. Misfolded
SOD1 accumulation in DRG neurons also elicits a neuroin-
flammatory response which is comparable to that observed
in ventral horn MNs [13, 14]; this indicates that the same
basic pathophysiological process, which leads to neuronal
loss, is involved in both cell populations. Degenerating DRG
neuronal somata displayed an extensive vacuolar pathology,
probably originated from disrupted ER, in the absence
of apoptotic nuclear changes. Myelinated axonal profiles
adjacent to DRG neuron somata often showed extremely
vacuolated mitochondria, with identical morphologies to
those characteristically observed in motor axons [32–34].
As these alterations appear to be induced by aggregates of
misfolded SOD1 in mitochondria and to correlate with the
exacerbation of disease [35, 36], their presencewithin sensory
axons would seem to point to a common SOD1-dependent
mechanism of mitochondrial swelling shared by both motor
and sensory axons.
From a qualitative point of view, degenerating changes
in the VRs and DRs displayed a Wallerian-like morphology,
with the alterations being substantially exacerbated in the
VRs. One of the early changes in sectioned axons is the dis-
solution of axoplasm, with the subsequent loss of cytoskeletal
components, organelles, and axolemma. This results in a
swollen axoplasm surrounded by intact myelin [20], which is
the predominant morphology we observed in the DRs. Later,
myelin debris appears engulfed by phagocytic/Schwann cells
leading to axonal loss when regenerative events are unable to
compensate for the injury. This is the morphological pattern
usually seen in VRs. However, this reduction in axonal
numbers is only prominent in VRs because the progression
of the degenerative process leading to axonal loss in DRs is
halted as a result of animal death. It should also be taken into
account that since there is no clear cut distinction between
normal and early degenerating axons in semithin sections,
the latter were also included in our counts.
Vacuolar degeneration is a common feature of the DRG
neuronal degeneration observed in a variety of conditions
including diabetes [37], Charcot-Marie-Tooth disease [38],
and bortezomib-induced neurotoxicity [39]. In our model,
extensive microvacuolization was observed in DRG neurons
that had presumably accumulated misfolded SOD1. Agents
like bortezomib are potent endoplasmic reticulum (ER) stres-
sors and lead to its vacuolar disruption. As misfolded SOD1
has been shown to play amajor role in ALSMNdegeneration
by inducing ER stress [40, 41], the microvacuolization that
we found in DRG neurons should be understood as a
consequence of misfolded SOD1-induced ER stress in a type
of neuron which is not usually considered a main target in
ALS.
One question which arises from our results is whether
misfolded-SOD1 accumulation in DRG neurons is a pri-
mary cell process similar to that occurring in ventral horn
motoneurons or, on the other hand, a consequence of cell-
to-cell spreading of misfolded-SOD1 conformers via a prion-
like mechanism.We should point out that the DRG neuronal
subpopulation that degenerate as a result of misfolded-SOD1
accumulation are large proprioceptive neurons, some of
which establish monosynaptic contacts with ventral horn
MNs. As it has been demonstrated in vitro that SOD1
misfolding and aggregation can propagate in a prion-like
manner in neuronal cells [42, 43] and it has been strongly
suggested that thismechanism could also operate in vivo [44],
our findings may provide support for this hypotheses.
5. Conclusion
Themisfolded SOD1-dependent degeneration of propriocep-
tive neurons that we have described here is a late event in the
natural history of ALS in the SOD1G93A fastmousemodel and
could be consistent with a prion-like spreading mechanism
that emerges in advanced stages of the disease. A more
precise determination of the alteration in the proprioceptive
system involving noninvasive procedures could be useful as a
biomarker of the progression of disease.
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